Here is what you need to know on Monday, August 29:
Equity markets begin the week on the back foot after a selling spree on Friday. Jackson put us all in a hole as Powell stepped up the hawkish narrative. Yields have now been marked up accordingly, but there may be more portfolio rebalancing ahead in the weeks to come.
Already Europe has opened lower, and US equity futures are looking at another 1% loss at a minimum on the open. The dollar remains in a kingpin position naturally after such a hawkish tilt, and that will also be a weight on US equities. This point has been overlooked in the last earnings quarter. We have had numerous earnings boasting of gains on a constant currency basis, but since then are currencies ever constant? US companies especially will be hit hard by the rising dollar. At least though it does somewhat offset energy inflation.
Many market participants pointed to the VIX remaining relatively subdued during Friday's rout, but fear not. It is up another few points with more to come this morning. Yields in Europe are all higher, and US yields are also moving higher this morning. In the past week, fed funds futures for December 2023 have priced in an additional 20 basis points of hikes, and Powell made it very clear he sees rates higher for longer. When you add in the growing hawkishness from the ECB, it seems risk assets are in for a tough few months ahead.
The dollar index is now at 108.90, while oil is higher at $93.50 on the back of Libya's problems and more talk of supply cuts from OPEC. Bitcoin suffered a tough weekend as it fell below $20,000 and is stable there this morning. Gold is at $1,728.
European markets are lower: Eurostoxx -0.4%, FTSE -0.6% and Dax -1%.
US futures also lower: S&P -0.9%, Dow -0.8% and Nasdaq -1.1%.
Wall Street top news (QQQ) (SPY)
Qualcomm (QCOM): EU will not appeal court decision against its 997 million euro fine-Reuters.
Netflix (NFLX) to charge $7 to $9 for ad service -Reuters.
Astra Zeneca (AZN) diabetes drug Farxiga sees good data.
Catalent (CTLT) drops on revenue missing estiamtes.
Pinduoduo (PDD) is up on strong earnings.
Moderna (MRNA) got Swiss approval for its new vaccine, which contains an omicron version.
Tellurian (TELL) down on the new issue.
Upgrades and downgrades
Source: WSJ.com
Economic releases
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD clings to daily gains above 1.0650
EUR/USD gained traction and turned positive on the day above 1.0650. The improvement seen in risk mood following the earlier flight to safety weighs on the US Dollar ahead of the weekend and helps the pair push higher.
GBP/USD recovers toward 1.2450 after UK Retail Sales data
GBP/USD reversed its direction and advanced to the 1.2450 area after touching a fresh multi-month low below 1.2400 in the Asian session. The positive shift seen in risk mood on easing fears over a deepening Iran-Israel conflict supports the pair.
Gold holds steady at around $2,380 following earlier spike
Gold stabilized near $2,380 after spiking above $2,400 with the immediate reaction to reports of Israel striking Iran. Meanwhile, the pullback seen in the US Treasury bond yields helps XAU/USD hold its ground.
Bitcoin Weekly Forecast: BTC post-halving rally could be partially priced in Premium
Bitcoin price shows no signs of directional bias while it holds above $60,000. The fourth BTC halving is partially priced in, according to Deutsche Bank’s research.
Week ahead – US GDP and BoJ decision on top of next week’s agenda
US GDP, core PCE and PMIs the next tests for the Dollar. Investors await BoJ for guidance about next rate hike. EU and UK PMIs, as well as Australian CPIs also on tap.